JAVIER SOLANO CASTÁN

Mr. JAVIER SOLANO CASTÁN


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
AMALBA SIMÓN MELCHOR
ALBA SIMÓN MELCHOR
DBDaniel Bordonaba Bosque
Daniel Bordonaba Bosque
Olimpio MonteroOlimpio Montero
Olimpio Montero
JCJAVIER SOLANO CASTÁN
JAVIER SOLANO CASTÁN
ICIrma Canales Caro
Irma Canales Caro
Background/Objectives: Type 2 diabetes mellitus (T2DM) is a metabolic disease whose importance rises with aging, though it is also looming large in younger populations due to increasing obesity. Its effects may damage renal and heart functioning. Plasma biomarkers of T2DM have been shown through metabolomic studies under different conditions, mainly obesity, but untargeted metabolomic studies on T2DM are lacking for elderly people. Methods: A UPLC-MS-based metabolomic approach was conducted to ascertain potential plasma biomarkers in a cohort older than 65 years. Results: The dipeptide Gly-His, along with diverse lysophosphatidylcholines (LPCs), mainly LPC(14:0) and LPC(20:4), and three gangliosides were found to have different plasma content in T2DM subjects compared to control (non-diabetic) subjects (NT2DM). LPC(20:4) exhibited a gender dependence, with statistically significant differences only in females. Gly-His correlated with MEDAS-14, whereas LPC(14:0) correlated with sugar-rich food consumption. Conclusions: As previously demonstrated for other conditions, mainly obesity, altered lipid metabolism was shown in this study to be a hallmark of T2DM in elderly people also.

6 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMALBA SIMÓN MELCHOR
ALBA SIMÓN MELCHOR
DBDaniel Bordonaba Bosque
Daniel Bordonaba Bosque
Olimpio MonteroOlimpio Montero
Olimpio Montero
JCJAVIER SOLANO CASTÁN
JAVIER SOLANO CASTÁN
ICIrma Canales Caro
Irma Canales Caro
Background/Objectives: Type 2 Diabetes Mellitus (DM2) is a metabolic disease whose importance rises with aging. Its effects may damage renal and heart functioning. Plasma biomarkers of DM2 have been shown through metabolomic studies under different conditions, mainly obesity, but untargeted metabolomic studies on DM2 were lacking for elderly people. Methods: A UPLC-MS-based metabolomics approach was conducted to ascertain potential plasma biomarkers in an older than 65 years cohort. Results: the dipeptide Gly-His, along with diverse lysophosphatidylcholines (LPCs), mainly LPC(14:0) and LPC(20:4), as well as three gangliosides, were found to have a different plasma content in DM2 subjects as compared to control (non-diabetic) subjects (NDM2). LPC(20:4) exhibited a gender dependence with statistically significant differences only in females. Gly-His correlated with MEDAS-14, whereas LPC(14:0) did with sugar-rich food consumption. Conclusions: as previously shown for other conditions, mainly obesity, altered lipid metabolism was shown in this study to be a hallmark of DM2 also in elderly people.